Cholesterol modulates LRP5 expression in the vessel wall


Por: Borrell-Pages, M, Romero, JC, Badimon, L

Publicada: 1 ago 2014
Resumen:
Objective: Macrophages are key players in atherosclerotic lesion formation and progression. We have recently demonstrated that lipid-loaded macrophages show activation of the canonical Wnt signaling pathway. Methods: To test the in vivo role of the canonical Wnt pathway in atherosclerosis we used mice deficient in the Wnt signaling receptor LRP5 (LRP5(-/-)) fed a hypercholesterolemic diet (HC) to induce atherosclerosis. These dietary groups were further subdivided into two subgroups receiving their respective diets supplemented with 2% plant sterol esters (PSE). All mice remained on their assigned diets until age 18 weeks. Results: HC WT mice had mildly increased non-HDL cholesterol levels, developed aortic atherosclerotic lesions and showed upregulated expression levels of aortic Lrp5. HC LRP5(-/-) mice develop larger aortic atherosclerotic lesions than WT mice indicating that LRP5 has a protective function in atherosclerosis progression. The oral administration of PSE, a dietary cholesterol-lowering agent, had an effect in the expression levels of the Wnt signaling receptor and in atherosclerosis progression. We found that PSE reduced serum total cholesterol levels, abolished HC-induced LRP5 overexpression and reduced aortic atherosclerotic plaques. Conclusion: The proatherogenic effects of the excess of plasma lipids are in part mediated by modulation of LRP5 in the aorta. LRP5 and canonical Wnt signaling exert a protective defense mechanism against hyperlipidemia and atherosclerosis lesion progression. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Filiaciones:
Borrell-Pages, M:
 Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr, CSIC ICCC, IIB St Pau, Barcelona, Spain

Romero, JC:
 Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr, CSIC ICCC, IIB St Pau, Barcelona, Spain

Badimon, L:
 Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr, CSIC ICCC, IIB St Pau, Barcelona, Spain

 UAB, Cardiovasc Res Chair, Barcelona, Spain
ISSN: 00219150





ATHEROSCLEROSIS
Editorial
ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND, Estados Unidos America
Tipo de documento: Article
Volumen: 235 Número: 2
Páginas: 363-370
WOS Id: 000342411000918
ID de PubMed: 24929284

MÉTRICAS